Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country
The objective of the present study was to determine the efficacy of detection of antigliadin immunoglobulins G and A (IgG and IgA) for the diagnosis of celiac disease in a developing country, since other enteropathies might alter the levels of these antibodies. Three groups were studied: 22 patients...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2001-11-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001001100007 |
id |
doaj-97cde98bbe944f638bd0ede8e283bbcf |
---|---|
record_format |
Article |
spelling |
doaj-97cde98bbe944f638bd0ede8e283bbcf2020-11-24T22:27:53ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2001-11-0134111415142010.1590/S0100-879X2001001100007Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing countryM. BahiaA. RabelloG. Brasileiro FilhoF.J. PennaThe objective of the present study was to determine the efficacy of detection of antigliadin immunoglobulins G and A (IgG and IgA) for the diagnosis of celiac disease in a developing country, since other enteropathies might alter the levels of these antibodies. Three groups were studied: 22 patients with celiac disease (mean age: 30.6 months), 61 patients with other enteropathies (mean age: 43.3 months), and 46 patients without enteropathies (mean age: 96.9 months). Antigliadin IgG and IgA ELISA showed sensitivity of 90.9 and 95.5%, respectively. With the hypothetical values of prevalence ranging from 1:500 to 1:2000 liveborns, the positive predictive value varied from 8.5 to 2.3% for IgG and from 4.8 to 1.1% for IgA. Considering the patients without enteropathies, specificity was 97.8 and 95.7% for IgG and IgA, respectively. In patients with other enteropathies, specificity was 82.0 and 84.1%, respectively. When patients with and without other enteropathies were considered as a whole, specificity was 88.8 and 91.6%, respectively. The specificity of positive IgG or IgA was 93.5% in children without enteropathies and 78.7% in the presence of other enteropathies. The negative predictive value for hypothetical prevalences varying from 1:500 to 1:2000 liveborns was 99.9%. Thus, even in developing countries where the prevalence of non-celiac enteropathies is high, the determination of serum antigliadin antibody levels is a useful screening test prior to the jejunal biopsy in the investigation of intestinal malabsorption.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001001100007celiac diseaseenteropathiesantigliadin antibodies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
M. Bahia A. Rabello G. Brasileiro Filho F.J. Penna |
spellingShingle |
M. Bahia A. Rabello G. Brasileiro Filho F.J. Penna Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country Brazilian Journal of Medical and Biological Research celiac disease enteropathies antigliadin antibodies |
author_facet |
M. Bahia A. Rabello G. Brasileiro Filho F.J. Penna |
author_sort |
M. Bahia |
title |
Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country |
title_short |
Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country |
title_full |
Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country |
title_fullStr |
Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country |
title_full_unstemmed |
Serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country |
title_sort |
serum antigliadin antibody levels as a screening criterion before jejunal biopsy indication for celiac disease in a developing country |
publisher |
Associação Brasileira de Divulgação Científica |
series |
Brazilian Journal of Medical and Biological Research |
issn |
0100-879X 1414-431X |
publishDate |
2001-11-01 |
description |
The objective of the present study was to determine the efficacy of detection of antigliadin immunoglobulins G and A (IgG and IgA) for the diagnosis of celiac disease in a developing country, since other enteropathies might alter the levels of these antibodies. Three groups were studied: 22 patients with celiac disease (mean age: 30.6 months), 61 patients with other enteropathies (mean age: 43.3 months), and 46 patients without enteropathies (mean age: 96.9 months). Antigliadin IgG and IgA ELISA showed sensitivity of 90.9 and 95.5%, respectively. With the hypothetical values of prevalence ranging from 1:500 to 1:2000 liveborns, the positive predictive value varied from 8.5 to 2.3% for IgG and from 4.8 to 1.1% for IgA. Considering the patients without enteropathies, specificity was 97.8 and 95.7% for IgG and IgA, respectively. In patients with other enteropathies, specificity was 82.0 and 84.1%, respectively. When patients with and without other enteropathies were considered as a whole, specificity was 88.8 and 91.6%, respectively. The specificity of positive IgG or IgA was 93.5% in children without enteropathies and 78.7% in the presence of other enteropathies. The negative predictive value for hypothetical prevalences varying from 1:500 to 1:2000 liveborns was 99.9%. Thus, even in developing countries where the prevalence of non-celiac enteropathies is high, the determination of serum antigliadin antibody levels is a useful screening test prior to the jejunal biopsy in the investigation of intestinal malabsorption. |
topic |
celiac disease enteropathies antigliadin antibodies |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001001100007 |
work_keys_str_mv |
AT mbahia serumantigliadinantibodylevelsasascreeningcriterionbeforejejunalbiopsyindicationforceliacdiseaseinadevelopingcountry AT arabello serumantigliadinantibodylevelsasascreeningcriterionbeforejejunalbiopsyindicationforceliacdiseaseinadevelopingcountry AT gbrasileirofilho serumantigliadinantibodylevelsasascreeningcriterionbeforejejunalbiopsyindicationforceliacdiseaseinadevelopingcountry AT fjpenna serumantigliadinantibodylevelsasascreeningcriterionbeforejejunalbiopsyindicationforceliacdiseaseinadevelopingcountry |
_version_ |
1725748520984510464 |